These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 10465106

  • 1. Autologous bone marrow transplantation after histologic transformation of indolent B cell malignancies.
    Friedberg JW, Neuberg D, Gribben JG, Mauch P, Anderson KC, Soiffer RJ, Takvorian T, Fisher DC, Schlossman R, Jallow H, Kuhlman C, Ritz J, Freedman AS.
    Biol Blood Marrow Transplant; 1999; 5(4):262-8. PubMed ID: 10465106
    [Abstract] [Full Text] [Related]

  • 2. Clinical outcome following autologous and allogeneic blood and marrow transplantation for relapsed diffuse large-cell non-Hodgkin's lymphoma.
    Aksentijevich I, Jones RJ, Ambinder RF, Garrett-Mayer E, Flinn IW.
    Biol Blood Marrow Transplant; 2006 Sep; 12(9):965-72. PubMed ID: 16920563
    [Abstract] [Full Text] [Related]

  • 3. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB.
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [Abstract] [Full Text] [Related]

  • 4. Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study.
    Colombat P, Cornillet P, Deconinck E, Tourani JM, Gardembas M, Delain M, Abgrall JF, Kootz C, Milpied N.
    Bone Marrow Transplant; 2000 Nov; 26(9):971-7. PubMed ID: 11100276
    [Abstract] [Full Text] [Related]

  • 5. Monoclonal antibody-purged autologous bone marrow transplantation in adults with acute lymphoblastic leukemia at high risk of relapse.
    Soiffer RJ, Roy DC, Gonin R, Murray C, Anderson KC, Freedman AS, Rabinowe SN, Robertson MJ, Spector N, Pesek K.
    Bone Marrow Transplant; 1993 Sep; 12(3):243-51. PubMed ID: 8241984
    [Abstract] [Full Text] [Related]

  • 6. Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma.
    de Lima M, van Besien KW, Giralt SA, Khouri IF, Mehra R, Andersson BS, Przepiorka D, Gajewski JL, Korbling M, Champlin RE.
    Bone Marrow Transplant; 1997 Jan; 19(2):121-7. PubMed ID: 9116608
    [Abstract] [Full Text] [Related]

  • 7. Autologous bone marrow transplantation with negative immunomagnetic purging for aggressive B-cell non-Hodgkin's lymphoma in first complete remission.
    De Rosa L, Lalle M, Pandolfi A, Ruscio C, Amodeo R.
    Ann Hematol; 2002 Oct; 81(10):575-81. PubMed ID: 12424539
    [Abstract] [Full Text] [Related]

  • 8. High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission.
    Freedman AS, Neuberg D, Gribben JG, Mauch P, Soiffer RJ, Fisher DC, Anderson KC, Andersen N, Schlossman R, Kroon M, Ritz J, Aster J, Nadler LM.
    J Clin Oncol; 1998 Jan; 16(1):13-8. PubMed ID: 9440717
    [Abstract] [Full Text] [Related]

  • 9. Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis.
    Takvorian T, Canellos GP, Ritz J, Freedman AS, Anderson KC, Mauch P, Tarbell N, Coral F, Daley H, Yeap B.
    N Engl J Med; 1987 Jun 11; 316(24):1499-505. PubMed ID: 3295542
    [Abstract] [Full Text] [Related]

  • 10. Bone marrow transplantation in 46 pediatric patients with non-Hodgkin's lymphoma. Spanish Working Party for Bone Marrow Transplantation in Children.
    Bureo E, Ortega JJ, Muñoz A, Cubells J, Madero L, Verdaguer A, Baro J, Olivé T, Maldonado MS, Pardo N.
    Bone Marrow Transplant; 1995 Mar 11; 15(3):353-9. PubMed ID: 7599558
    [Abstract] [Full Text] [Related]

  • 11. High-dose therapy supported with immunomagnetic purged autologous bone marrow in high-grade B cell non-Hodgkin's lymphoma.
    Blystad A, Kvalheim G, Torlakovic E, Holte H, Jacobsen E, Beiske K, Vâlerhaugen H, Lenschow E, Kvaloy S.
    Bone Marrow Transplant; 1999 Oct 11; 24(8):865-72. PubMed ID: 10516698
    [Abstract] [Full Text] [Related]

  • 12. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
    Huang HQ, Bu Q, Xia ZJ, Lin XB, Wang FH, Li YH, Peng YL, Pan ZH, Wang SS, Lin TY, Jiang WQ, Guan ZZ.
    Ai Zheng; 2006 Apr 11; 25(4):486-9. PubMed ID: 16613686
    [Abstract] [Full Text] [Related]

  • 13. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
    Papajík T, Jedlicková K, Kriegová E, Jarosová M, Raida L, Faber E, Hubácek J, Vondráková J, Pikalová Z, Indrák K.
    Neoplasma; 2001 Apr 11; 48(6):501-5. PubMed ID: 11949845
    [Abstract] [Full Text] [Related]

  • 14. Prolonged disease-free survival after ablative chemoradiotherapy and autologous bone marrow transplantation in adult malignant lymphoma.
    Da WM, Zhong JT, Liu Y, Huang YS, Bai H, Wu XX, Ou YX, Wang CB, Xu SF.
    Chin Med J (Engl); 1993 Apr 11; 106(4):277-81. PubMed ID: 8325155
    [Abstract] [Full Text] [Related]

  • 15. 4-Hydroperoxycyclophosphamide purged autologous bone marrow transplantation in non-Hodgkin's lymphoma patients at high risk of bone marrow involvement.
    Bird JM, Luger S, Mangan P, Edelstein M, Silberstein L, Powlis W, Ball J, Schultz DJ, Stadtmauer EA.
    Bone Marrow Transplant; 1996 Aug 11; 18(2):309-13. PubMed ID: 8864439
    [Abstract] [Full Text] [Related]

  • 16. [Autologous stem-cell transplantations in children with non-Hodgkin lymphomas].
    Wójcik B, Kowalczyk JR, Chybicka A, Wachowiak J, Drabko K, Zaucha-Prazmo A, Choma M, Gorczyńska E, Toporski J, Turkiewicz D, Kałwak K, Pieczonka A, Boruczkowski D.
    Przegl Lek; 2004 Aug 11; 61 Suppl 2():53-6. PubMed ID: 15686047
    [Abstract] [Full Text] [Related]

  • 17. Autologous transplantation in patients with relapsed or high-grade follicular lymphoma provides long term disease-free survival and best median duration of response.
    Ganguly S, Divine CL, Deauna-Limayo D, Bodensteiner DC, Cook JD, Lewis JN, Skikne BS.
    Ann Hematol; 2005 Aug 11; 84(8):526-31. PubMed ID: 15915350
    [Abstract] [Full Text] [Related]

  • 18. Autologous stem cell transplantation (ASCT) with immunologically purged progenitor cells in patients with advanced stage follicular lymphoma after early partial or complete remission: toxicity, follow-up of minimal residual disease and survival.
    González-Barca E, Fernández de Sevilla A, Domingo-Claros A, Romagosa V, Martín-Henao GA, De Sanjose S, Carmona M, Petit J, García J, Grañena A.
    Bone Marrow Transplant; 2000 Nov 11; 26(10):1051-6. PubMed ID: 11108302
    [Abstract] [Full Text] [Related]

  • 19. Autologous bone marrow transplantation for progressive non-Hodgkin's lymphoma: clinical impact of immunophenotype and in vitro purging.
    Weisdorf DJ, Haake R, Miller WJ, McGlave PB, LeBien TW, Vallera DA, Lasky LC, Kim TH, Peterson BA, Ramsay NK.
    Bone Marrow Transplant; 1991 Aug 11; 8(2):135-42. PubMed ID: 1933055
    [Abstract] [Full Text] [Related]

  • 20. Role of hematopoietic stem cell transplantation for advanced-stage diffuse large cell B-cell lymphoma-B.
    Nademanee A, Forman SJ.
    Semin Hematol; 2006 Oct 11; 43(4):240-50. PubMed ID: 17027658
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.